Skip to main content
. 2022 May 31;3:100143. doi: 10.1016/j.crmicr.2022.100143

Table 1.

Characteristics of participants with normoglycemia and prediabetes

Characteristics Normoglycemia (N=20) Prediabetes (N=20) P-value
Demographic and anthropometric parameters
Age (years) 51.8±6.6 50.9±5.6 0.625
Male, N (%) 13 (65.0) 13 (65.0) >0.999
History of smoking, N (%) 10 (50.0) 7 (35.0) 0.337
History of alcohol drinking, N (%) 16 (80.0) 12 (60.0) 0.168
Underlying diseases, N (%)
Hypertension 4 (20.0) 3 (15.0) 0.677
Dyslipidemia 9 (45.0) 7 (35.0) 0.519
NAFLD 0 (0.0) 1 (5.0) 0.311
Body weight (kg) 62.7±12.8 63.7±12.4 0.814
Body mass index (kg/m2) 23.1±4.6 24.1±4.0 0.501
SBP (mmHg) 130.5±15.5 129.5±14.5 0.842
DBP (mmHg) 81.3±8.1 82.1±10.6 0.790
Waist circumference (cm) 84.8±10.8 85.4±10.7 0.878
Waist hip circumference ratio 0.91±0.07 0.91±0.06 0.825
HIV-related parameters
Duration of HIV infection (years) 15.2±6.1 14.4±5.4 0.682
Type of ART regimen, N (%)
NNRTI-based 13 (65.0) 13 (65.0) >0.999
PI-based 7 (35.0) 7 (35.0) >0.999
Duration of ART (years) 11.5±6.1 11.9±5.1 0.834
CD4 cell counts (cells/mm3) 559.8±264.0 475.0±204.5 0.263
Biochemical parameters
FPG (mg/dL) 91.8 ±7.9 101.4±13.6 0.009
2h PG (mg/dL) 113.5±37.0 138.7±37.3 0.041
HbA1c (%) 5.32±0.21 5.99±0.22 <0.001
Triglycerides (mg/dL) 130.5 (81.8 – 185.3) 134.0 (99.5 – 198.5) 0.379
HDL cholesterol (mg/dL) 51.2±11.6 46.2±11.4 0.181
LDL cholesterol (mg/dL) 141.3±36.0 130.0±33.4 0.308
Total cholesterol (mg/dL) 219.0±42.0 203.4±36.3 0.215

Data were presented as mean±SD or median (interquartile range).

2h PG = 2-h plasma glucose; ART = antiretroviral therapy; DBP = diastolic blood pressure; FPG = fasting plasma glucose; HbA1c = hemoglobin A1c; HDL = high-density lipoprotein; LDL= low-density lipoprotein; NAFLD = non-alcoholic fatty liver disease; NNRTI = non-nucleoside reverse transcriptase inhibitor; PI = protease inhibitor; SBP = systolic blood pressure